| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000184274.3 |
Ponatinib |
Pancreatic adenocarcinoma |
0.034815287 |
Resistant |
| ENSG00000184274.3 |
Ponatinib |
Bladder urothelial carcinoma |
0.048929141 |
Sensitive |
| ENSG00000184274.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.012596055 |
Sensitive |
| ENSG00000184274.3 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.039870098 |
Sensitive |
| ENSG00000184274.3 |
Ponatinib |
Skin cutaneous melanoma |
0.012656331 |
Sensitive |
